Xencor (NASDAQ:XNCR) shares lost ~13% on Tuesday as the company refuted concerns over an upcoming data readout from an early-stage trial for its kidney cancer drug, XmAb819, scheduled to be presented ...
Shares of Schrödinger (NASDAQ:SDGR) fell on Thursday after the AI-focused biotech posted initial data from a Phase 1 trial for SGR-1505, an experimental therapy targeting relapsed/refractory B-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback